Catalyst Wire Dossier Catalyst Wire Dossier

Zefylti

filgrastim · CuraTeQ Biologics s.r.o.
Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for Zefylti, covering 2023-08-30 to 2026-07-14. Get the full timeline:

Most recent: EMA Authorised: Zefylti (filgrastim) — CuraTeQ Biologics (Malta) Limited

See pricing